AI Health Deployment Eko Health has a robust AI-powered platform for early detection of heart and lung diseases with FDA-cleared technology and a growing device base. Potential sales opportunity: offer expanded AI analytics services, integration with hospital EHR systems, and expanded device adoption across clinics and health systems.

International Expansion Recent international expansion into the UK and Canada signals readiness to scale. Potential sales opportunity: partner with regional distributors and health networks, tailor compliance and reimbursement strategies, and cross-sell CORE 500 telehealth and AI-stethoscope solutions to new markets.

Clinical Leadership New appointments of a Distinguished Medical Advisor and a Chief Medical Officer strengthen clinical credibility. Potential sales opportunity: leverage thought leadership for case studies, pilot programs, and larger scale deployments in multi-site health systems.

Integrated Solutions Product portfolio includes digital stethoscopes, patient and provider software, and telehealth capabilities with CPT coding progress. Potential sales opportunity: bundle hardware with software subscriptions, pursue payer reimbursement discussions, and accelerate telehealth adoption in cardiology and pulmonology practices.

Healthcare Partnerships Recent collaborations with Boehringer Ingelheim for veterinary applications indicate a willingness to co-develop with global partners. Potential sales opportunity: explore cross-industry partnerships in human and animal health, expand OEM or co-branded offerings, and identify enterprise customers seeking AI-driven cardiovascular solutions.